Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.

Prihantono PrihantonoMochammad HattaChristian BinekadaDaniel SampepajungHaryasena HaryasenaBerti NelwanAndi Asadul IslamAndi Nilawati Usman

Published in: Journal of oncology (2017)

These results suggest that Ki-67 expression detected by both IHC and qRT-PCR is considered to be a predictor of clinical response to neoadjuvant chemotherapy in locally advanced breast cancer.

Keyphrases

neoadjuvant chemotherapy
locally advanced
rectal cancer
squamous cell carcinoma
sentinel lymph node
poor prognosis
lymph node
radiation therapy
phase ii study
binding protein
high resolution
young adults
open label
study protocol
breast cancer risk
real time pcr